Faculty Publications

Faculty of the Emory Department of Urology publish regularly in the peer reviewed literature and various high impact journals, and typically collaborate across disciplines in the process of conducting, documenting, and authoring their studies.

RECENT PUBLICATIONS WITH ABSTRACTS

"Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy." Bilen MA, Shabto JM, Martini DJ, Liu Y, Lewis C, Collins H, Akce M, Kissick H, Carthon BC, Shaib WL, Alese OB, Steuer CE, Wu C, Lawson DH, Kudchadkar R, Master VA, El-Rayes B, Ramalingam SS, Owonikoko TK, Harvey RD. BMC Cancer. 2019 Aug 29;19(1):857.

"Feasibility and initial results: Fluciclovine positron emission tomography/ultrasound fusion targeted biopsy of recurrent prostate cancer." Fei B, Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo O, Tade F, Nieh PT, Master VA, Alemozaffar M, Osunkoya AO, Goodman MM, Schuster DM. Journal of Urology. 2019 Aug;202(2):413-421.

"High-dose-rate prostate brachytherapy appears safe in patients with high baseline International Prostate Symptom Scores." Morgan TM, Rossi PJ, Cutrell PK, Zhang C, Press RH, Rahnema S, Sanda M, Pattaras J, Cimmino C, Hershatter B, Jani AB, Patel PR. Brachytherapy. 2019 Jul 20. [Epub ahead of print]

"A four-group urine risk classifier for predicting outcome in prostate cancer patients." Connell SP, Hanna M, McCarthy F, Hurst R, Webb M, Curley H, Walker H, Mills R, Ball RY, Sanda MG, Pellegrini KL, Patil D, Perry AS, Schalken J, Pandha H, Whitaker H, Dennis N, Stuttle C, Mills IG, Guldvik I; Movember GAP1 Urine Biomarker Consortium, Parker C, Brewer DS, Cooper CS, Clark J. BJU International. 2019 May 20. [Epub ahead of print]

"What patients and partners want in interventions that support sexual recovery after prostate cancer treatment: An exploratory convergent mixed methods study." Mehta A, Pollack CE, Gillespie TW, Duby A, Carter C, Thelen-Perry S, Witmann D. The Journal of Sexual Medicine. 2019 Mar 1. [Epub ahead of print]

"Feasibility and initial results: Fluciclovine PET/Ultrasound fusion targeted biopsy of recurrent prostate cancer." Fei B, Abiodun-Ojo OA, Akintayo AA, Akin-Akintayo O, Tade F, Nieh PT, Master VA, Alemozaffar M, Osunkoya AO, Goodman MM, Schuster DM. Journal of Urology. 2019 Feb 28. [Epub ahead of print]

"Preoperative metabolic signatures of prostate cancer recurrence following radical prostatectomy." Clendinen CS, Gaul DA, Monge ME, Arnold RS, Edison AS, Petros JA, Fernandez FM. Journal of Proteome Research. 2019 Feb 13. [Epub ahead of print]